{
  "first_published_at": "2010-08-09", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON090903", 
  "title": "Topical ketoprofen: reminder on risk of photosensitivity reactions", 
  "tags": "{\"parsed_therapeutic\": [\"pain-management-palliation\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Pain management and palliation\"]}", 
  "_document_number": 190, 
  "label": "Reminder", 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/adverse_icon.png", 
  "therapeutic_area": [
    "pain-management-palliation"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Topical ketoprofen: reminder on risk of photosensitivity reactions</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: August 2010</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--The European Medicines Agency Committee for Medicinal Products for Human Use has recently completed a review of the medicine&#8217;s safety and efficacy, and has concluded that further measures should be put in place to minimise the risk of adverse skin reactions.-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>Healthcare professionals are reminded of the risk of photosensitivity reactions associated with <strong>topical ketoprofen</strong>.</p><p>The European Medicines Agency Committee for Medicinal Products for Human Use has recently completed a review of the medicine&rsquo;s safety and efficacy, and has concluded that further measures should be put in place to minimise the risk of adverse skin reactions.</p><p>Further information can be found on the <a href=\"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/07/news_detail_001060.jsp\" target=\"_blank\">European Medicines Agency&rsquo;s website</a>.</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Advice for healthcare professionals:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>Patients should ensure that treated areas are protected from sunlight during the whole period of topical ketoprofen treatment and for 2 weeks after stopping treatment; they should also carefully wash their hands after every application</li>\r\n\t\t\t\t<li>Patients should stop treatment immediately if they develop any skin reaction after application of these medicines and seek their doctor&rsquo;s advice</li>\r\n\t\t\t\t<li>Patients should be informed of the appropriate use of topical ketoprofen as outlined in the product information</li>\r\n\t\t\t</ul></div><p>See also <a href=\"ssLINK/CON088098\" target=\"_blank\">Drug Safety Update, June 2009</a>.</p><p>&nbsp;</p><p><em>Article citation: Drug Safety Update Aug 2010, vol&nbsp;4 issue 1: S3.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>Healthcare professionals are reminded of the risk of photosensitivity reactions associated with <strong>topical ketoprofen</strong>.</p><p>The European Medicines Agency Committee for Medicinal Products for Human Use has recently completed a review of the medicine&#8217;s safety and efficacy, and has concluded that further measures should be put in place to minimise the risk of adverse skin reactions.</p><p>Further information can be found on the <a href=\"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/07/news_detail_001060.jsp\" target=\"_blank\">European Medicines Agency&#8217;s website</a>.</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Advice for healthcare professionals:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>Patients should ensure that treated areas are protected from sunlight during the whole period of topical ketoprofen treatment and for 2 weeks after stopping treatment; they should also carefully wash their hands after every application</li>\r\n\t\t\t\t<li>Patients should stop treatment immediately if they develop any skin reaction after application of these medicines and seek their doctor&#8217;s advice</li>\r\n\t\t\t\t<li>Patients should be informed of the appropriate use of topical ketoprofen as outlined in the product information</li>\r\n\t\t\t</ul></div><p>See also <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON088098\" target=\"_blank\">Drug Safety Update, June 2009</a>.</p><p>&#160;</p><p><em>Article citation: Drug Safety Update Aug 2010, vol&#160;4 issue 1: S3.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2010-08-01", 
  "date_last_modified": "2010-09-17", 
  "_assets": [], 
  "_item_id": 190, 
  "summary": "", 
  "body": "Article date: August 2010\n\nHealthcare professionals are reminded of the risk of photosensitivity reactions associated with topical ketoprofen.\n\nThe European Medicines Agency Committee for Medicinal Products for Human Use has recently completed a review of the medicine’s safety and efficacy, and has concluded that further measures should be put in place to minimise the risk of adverse skin reactions.\n\nFurther information can be found on the [European Medicines Agency’s website](http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/07/news_detail_001060.jsp).\n\nAdvice for healthcare professionals:  \n  \n  * Patients should ensure that treated areas are protected from sunlight during the whole period of topical ketoprofen treatment and for 2 weeks after stopping treatment; they should also carefully wash their hands after every application  \n  * Patients should stop treatment immediately if they develop any skin reaction after application of these medicines and seek their doctor’s advice  \n  * Patients should be informed of the appropriate use of topical ketoprofen as outlined in the product information  \n  \nSee also [Drug Safety Update, June 2009](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON088098).\n\n \n\nArticle citation: Drug Safety Update Aug 2010, vol 4 issue 1: S3.\n"
}